Pamela Coleman

Associate Professor of Surgery

Howard University

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Imaging Medical Imaging professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Pamela Coleman is an Associate Professor of Surgery at Howard University, located in the United States. Her research interests include the implications of parental leave coverage in surgical practices, guidelines for urology, and the impact of racial composition on prostate cancer treatment disparities. She has recently contributed to discussions in her field through articles addressing these critical areas.

Articles (11)

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (7)

Ian S Dayes

McMaster University

CANADA

View details

Geoffrey Ibbott

Emeritus Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Yilun Sun

Assistant Professor

Case Western Reserve University

UNITED STATES

View details

Juanita Crook

professor

BC Cancer

CANADA

View details

Robert Dess

University of Michigan

UNITED STATES

View details

Grant Williams

Associate Professor

The University of Alabama

UNITED STATES

View details

Daniel E Spratt

University Hospitals Seidman Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Pamela Coleman

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Point-Counterpoint: Compensation for Parental Leave Coverage

Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126

AUA/ASTRO 2022 Guidelines: “Scrutinized”

Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials

Author Correction: Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials (npj Digital Medicine, (2022), 5, 1, (71), 10.1038/s41746-022-00613-w)

Effect of Brachytherapy with External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial

Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial

Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer

Re: Understanding the Role of Urology Practice Organization and Racial Composition in Prostate Cancer Treatment Disparities

Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials

Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial

Collaborators (7)

Ian S Dayes

Geoffrey Ibbott

Yilun Sun

Juanita Crook

Robert Dess

Grant Williams

Daniel E Spratt

Make your next move.